VIR | Vir Biotechnology Inc
Category: Consumer goods
Quick infos Headquarters: San Francisco, California, United States Trade prices Volume: Market Cap: 3.42B Prev closed: Open: 25.52 High: 26.52 Low: 24.6 52 week low: 21.32 52 week high: 58 Dividends: No Dividends Next ER: August 4, 2022 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast November 3, 2022 August 4, 2022 - / 0.0925- / 161.59MMay 5, 2022 3.85 / 3.781.23B / 811.05MFebruary 24, 2022 3.92 / 2.63812.75M / 622.96MBeat! November 4, 2021 0.82 / -0.0475103.62M / 138.25Mview more
Historical Data Date Price Open High Low Vol Change ER Aug 4, 2022 29.25 29.05 29.43
28.22
749.56K 0.83% Aug 3, 2022 29.01 28.52 29.74
28.42
573.02K 3.90% Aug 2, 2022 27.92 27.18 28.49
27.18
572.72K 1.79% Aug 1, 2022 27.43 27.79 28.35
27.12
726.05K -1.37% Jul 29, 2022 27.81 28.17 28.71
27.22
640.89K -3.94% Jul 28, 2022 28.95 29.81 29.81
28.82
621.11K -2.26% Jul 27, 2022 29.62 29.08 29.70
28.62
505.76K 2.31% Jul 26, 2022 28.95 29.33 29.70
28.78
602.71K -1.4% Jul 25, 2022 29.36 29.03 29.55
28.69
394.29K 1.35% Jul 22, 2022 28.97 30.00 30.00
28.70
620.89K -3.95% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:7 April 2016 Employees:367 News
Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference finance.yahoo.com Jul 15, 2022 4:02 pm
AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies finance.yahoo.com Jul 15, 2022 3:05 pm
Vir Biotechnology, Inc. (VIR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release finance.yahoo.com Jul 15, 2022 3:02 pm Why Shares of Vir Biotechnology Rose 20.4% This Week fool.com Jul 15, 2022 12:43 pm Vir's stock is up 12% after news it will join the S&P SmallCap 600 marketwatch.com Jul 15, 2022 9:31 am The Petri Dish: Adagio says its antibody works against omicron now bizjournals.com Jul 15, 2022 6:00 am Vir Biotechnology announces transition of chief scientific officer seekingalpha.com Jul 14, 2022 8:49 pm NIH launches $1.2B long COVID study involving nearly 40,000 people seekingalpha.com Jul 8, 2022 10:12 pm Vir Biotechnology reports data from Hepatitis B program seekingalpha.com Jun 27, 2022 7:26 pm Buy the Dip on These 3 Healthcare Stocks fool.com Jun 19, 2022 11:25 am
Vir Biotechnology (NASDAQ:VIR) shareholders are up 4.2% this past week, but still in the red over the last year finance.yahoo.com Jul 15, 2022 1:00 pm
Antibody Treatments for COVD-19 Face Challenges in the U.S. finance.yahoo.com Jul 15, 2022 9:31 am
Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day finance.yahoo.com Jul 15, 2022 8:39 am
Vir Biotechnology Announces Transition of Chief Scientific Officer finance.yahoo.com Jul 14, 2022 8:30 am
Vir Biotechnology, Inc.'s (NASDAQ:VIR) Stock Is Going Strong: Is the Market Following Fundamentals? finance.yahoo.com Jul 6, 2022 2:22 pm
Immatics (IMTX) Stock Jumps 5.2%: Will It Continue to Soar? finance.yahoo.com Jun 27, 2022 10:47 am Long COVID risk lower during Omicron – U.K. study seekingalpha.com Jun 17, 2022 6:23 pm
What Percentage Of Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Do Insiders Own? finance.yahoo.com Jun 6, 2022 1:20 pm Long COVID seen with one in five COVID survivors in U.S. - CDC study seekingalpha.com May 26, 2022 12:06 am COVID-19 sales boom for vaccine and drug makers might be over - analysts seekingalpha.com May 24, 2022 9:29 pm This company doesn't provide a dividend.
Key Persons Talk about Vir Biotechnology Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
